Tony Pelz

Contributor to TheStreet

Email This Author

Tony Pelz was a trader on a major European bank's proprietary trading desk, responsible for a portfolio with limits of more than $200 million. Prior to proprietary trading, Pelz worked with several global investment banks in roles ranging from corporate finance, M&A to credit and business development. He is author of The Biotech Trader Handbook, 2nd Edition, co-founder of the small-cap biotech research and trading site Chimera Research Group and operator of PelzOptions.com. Pelz currently resides in Denver, Colorado where he trades for his own account.

By This Author:

« Back

Page 2 of 2

Article

How To Trade Peregrine Pharma's Lung Cancer Fiasco

By Tony Pelz

Options expert Tony Pelz outlines a short-biased trade to play Peregrine's decline.

08:00AM 10/01/12

Article

Options 'Flow' Foretold Questcor Plunge

By Tony Pelz

Tony Pelz shows investors how to monitor unusual options trades to manage risk.

07:23AM 09/24/12

Article

Sarepta Therapeutics: A High-Octane Options Trade

By Tony Pelz

Tony Pelz offers an options trading strategy for investing in Sarepta and next month's eteplirsen data presentation.

09:33AM 09/17/12

Article

Trading Biotech With Options: Exelixis

By Tony Pelz

Tony Pelz debuts a new column focused on using options to invest and trade in biotech stocks.

11:54AM 09/10/12

« Back

Page 2 of 2

Select the service that is right for you!

COMPARE ALL SERVICES

Action Alerts PLUS

TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:

$2.5+ million portfolio
Large-cap and dividend focus
Intraday trade alerts from Cramer
Weekly roundups

Dividend Stock Advisor

TRY IT FREE

New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:

Diversified model portfolio of dividend stocks
Alerts when market news affect the portfolio
Bi-weekly updates with exact steps to take - BUY, HOLD, SELL

Stocks Under $10

TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:

Model portfolio
Stocks trading below $10
Intraday trade alerts
Weekly roundups

Real Money

TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:

Jim Cramer + 20 Wall Street pros
Intraday commentary & news
Real-time trading forum
Actionable trade ideas

Real Money Pro

TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:

Real Money + Doug Kass + 15 more Wall Street Pros
Intraday commentary & news
Ultra-actionable trading ideas

Options Profits

TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:

100+ monthly options trading ideas
Actionable options commentary & news
Real-time trading community
Options TV

DOW	15,354.40	121.18 0.80%
NASDAQ	3,498.97	33.73 0.97%

S&P 500	1,667.47	17.00 1.03%
US 10 Yr	1.949%	+0.084

Advertising Partners

Free Newsletters from TheStreet

We respect your privacy.

Manage Newsletters

Tony Pelz

Contributor to TheStreet

Select the service that is right for you!

Action Alerts PLUS

Product Features:

Dividend Stock Advisor

New! $49.95/yr

Product Features:

Stocks Under $10

Product Features:

Real Money

Product Features:

Real Money Pro

Product Features:

Options Profits

Product Features:

Brokerage Partners

Most Commented